The role of Cyclin Dependent Kinase Inhibitor 3 () in promoting human tumors: Literature review and pan-cancer analysis.

BACKGROUND

Although many experiments and clinical studies have proved the link between the expression of and human tumors, we have not been able to identify any bioinformatics study in which the extensive tumor-promoting effect of was systematically analyzed.

OBJECTIVE

Explore the extensive tumor-promoting effects of and review the research progress of in cancer.

METHODS

We systematically reviewed the literature on and tumors. We explored the potential tumor-promoting effects of on different tumors in the TCGA database and the GTEx database using multiple platforms and websites. We studied the expression level of , survival, prognosis, diagnosis, genetic variation, immune infiltration, and enrichment analysis using databases such as TIMER 2.0, GEPIA2, cBioPortal, and STRING.

RESULTS

We found that is highly expressed in most tumors. The expression of is closely related to the prognosis of some tumors. And may have diagnostic value. The conclusion of our literature review is roughly the same, but there are differences, which are worthy of further study. Moreover, may be related to immune cell infiltration in tumor tissues. The genetic alteration of LUAD, STAD, SARC, PCPG, and ESCA with "Amplification" as the main type. In addition, through enrichment analysis, we found that affects tumors mainly through the control of the cell cycle and mitosis.

CONCLUSION

is highly expressed in most tumor tissues and has a statistical correlation with survival prognosis. It has extensive tumor-promoting effects that may be related to mechanisms such as immune infiltration.